Chaguturu Sreekanth K
Known title: EVP and Chief Medical OfficerCIK: 0001928726
Associated companies
Transaction History
| CVS | ▼ Sell | Tax Withholding | 1,473 | $117K | 4/1/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 825 | $66K | 4/1/2024 | View on chart |
| CVS | ▲ Buy | Grant | 6,913 | $550K | 4/1/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 355 | $27K | 2/26/2024 | View on chart |
| CVS | ▲ Buy | Grant | 1,926 | $0 | 2/12/2024 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 1,854 | $138K | 4/1/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 120 | $10K | 2/28/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 318 | $27K | 2/27/2023 | View on chart |
| CVS | ▼ Sell | Tax Withholding | 442 | $45K | 11/29/2022 | View on chart |
| CVS | ▲ Buy | Grant | 12,735 | $0 | 8/31/2022 | View on chart |
| CVS | ▲ Buy | Grant | 12,919 | $0 | 5/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status
CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.
CVS Health News: Caremark Shift, Settlement Deadline, Defensive Status. CVS Caremark is changing how patients access health services, according to a recent report. The company also faces a settlement claim deadline a month away, with guidance on how to receive the funds. Analysts note that CVS is among a few defensive healthcare stocks being watched as rates remain high, and it has recently outperformed market returns.